1 year return (CAGR)
-19.44%
Altimmune Inc Exchange (NASDAQ, USD)
ALT
3.19
-0.22 (-6.45%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
5.59%
5 year return (CAGR)
-28.04%
10 year return (CAGR)
-42.41%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
620.51M
Price/Sales
20016.50
Ent value
610.47M
Price/Book
1.31
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-12.17%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.42 |
| Daily high | 3.42 |
| Daily low | 3.15 |
| Daily Volume | 4.51M |
| All-time high | 2724.00 |
| 1y analyst estimate | 17.22 |
| Beta | 0.18 |
| EPS (TTM) | -0.49 |
| Dividend per share | 0.00 |
| Ex-div date | 6 Feb 2017 |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ALT | S&P500 | |
| Current price drop from All-time high | -99.88% | -1.29% |
| Highest price drop | -99.94% | -56.47% |
| Date of highest drop | 19 Nov 2019 | 9 Mar 2009 |
| Avg drop from high | -81.27% | -10.68% |
| Avg time to new high | 249 days | 12 days |
| Max time to new high | 5128 days | 1805 days |
News
